SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
The PFRDA has published the phase 2 result of Grade A vacancies in various discipline on 13 2025. Candidates who qualify the ...
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...
AnaptysBio has abandoned plans to develop rosnilimab for ulcerative colitis (UC) after the PD-1 agonist flunked a phase 2 study.
Rigel Pharmaceuticals (RIGL) announced a peer-reviewed publication in the Journal of Hematology & Oncology of the final five-year data from the ...
Get the complete IFSCA Grade A Phase 2 Exam Analysis 2025 with difficulty level, section-wise review, and all memory-based ...
The next round includes new Conservatory Complex and education facilities at the downtown Sarasota destination.
Mutuum Finance (MUTM) is entering one of its most important development stages. The project has been moving steadily across ...
Plans add clinical, laboratory, office, residential, retail, and hospitality space, plus more than 12 acres of public green ...
To make matters worse, Union Minister G Kishan Reddy recently stated that the updated Detailed Project Report for Phase-II, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback